The CXCL10/CXCR3 Axis Mediates Human Lung Mast Cell Migration to Asthmatic Airway Smooth Muscle
Top Cited Papers
- 15 May 2005
- journal article
- clinical trial
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 171 (10) , 1103-1108
- https://doi.org/10.1164/rccm.200409-1220oc
Abstract
Mast cell microlocalization within the airway smooth muscle bundle is an important determinant of the asthmatic phenotype. We hypothesized that mast cells migrate toward airway smooth muscle in response to smooth muscle-derived chemokines. In this study, we investigated (1) chemokine receptor expression by mast cells in the airway smooth muscle bundle in bronchial biopsies from subjects with asthma using immunohistology, (2) the concentration of chemokines in supernatants from stimulated ex vivo airway smooth muscle cells from subjects with and without asthma measured by enzyme-linked immunosorbent assay, and (3) mast cell migration toward these supernatants using chemotaxis assays. We found that CXCR3 was the most abundantly expressed chemokine receptor on human lung mast cells in the airway smooth muscle in asthma and was expressed by 100% of these mast cells compared with 47% of mast cells in the submucosa. Human lung mast cell migration was induced by airway smooth muscle cultures predominantly through activation of CXCR3. Most importantly, CXCL10 was expressed preferentially by asthmatic airway smooth muscle in bronchial biopsies and ex vivo cells compared with those from healthy control subjects. These results suggest that inhibition of the CXCL10/CXCR3 axis offers a novel target for the treatment of asthma.Keywords
This publication has 39 references indexed in Scilit:
- Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactionsJournal of Allergy and Clinical Immunology, 2003
- Regulation of TNF‐α and IFN‐γ induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary diseaseThe FASEB Journal, 2003
- Tryptase‐stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell ChemotaxisThe FASEB Journal, 2003
- IL-4, BUT NOT IL-13, MODULATES TARC (THYMUS AND ACTIVATION-REGULATED CHEMOKINE)/CCL17 AND IP-10 (INTERFERON-INDUCED PROTEIN OF 10 kDa)/CXCL10 RELEASE BY TNF-α AND IFN-γ IN HaCaT CELL LINECytokine, 2002
- T helper type 1 cells in asthma: friend or foe?Current Opinion in Allergy and Clinical Immunology, 2002
- Expression of IFN-γ–inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseasesJournal of Allergy and Clinical Immunology, 2001
- The Ligands of CXC Chemokine Receptor 3, I-TAC, Mig, and IP10, Are Natural Antagonists for CCR3Journal of Biological Chemistry, 2001
- Tryptase-Chymase Double-Positive Human Mast Cells Express the Eotaxin Receptor CCR3 and Are Attracted by CCR3-Binding ChemokinesThe American Journal of Pathology, 1999
- The Mast Cell as a Source of Cytokines in AsthmaAnnals of the New York Academy of Sciences, 1996
- Immunohistochemistry on Resin Sections: A Comparison of Resin Embedding Techniques for Small Mucosal BiopsiesBiotechnic & Histochemistry, 1993